Matthew A. Spear - 09 Sep 2021 Form 4 Insider Report for Poseida Therapeutics, Inc.

Role
Chief Medical Officer
Signature
/s/ Harry J. Leonhardt, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
09 Sep 2021
Net transactions value
+$13,220
Form type
4
Filing time
10 Sep 2021, 16:19:08 UTC
Previous filing
24 Aug 2021
Next filing
08 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PSTX Common Stock Options Exercise $13,220 +10,000 +24% $1.32 51,485 09 Sep 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PSTX Stock Option (Right to Buy) Options Exercise $0 -10,000 -11% $0.000000 80,861 09 Sep 2021 Common Stock 10,000 $1.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested and exercisable.